This article explores the complexities of determining resectability in patients with non-small cell lung cancer (NSCLC). The authors emphasize that resectability, crucial for deciding treatment pathways, is best assessed by a multidisciplinary tumor board but lacks a standardized definition across clinical guidelines and trials.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Thoracic Guidelines
March 23, 2023
Thoracic oncology patients are a high-risk group for venous thromboembolism (VTE). The ESTS and AATS panel reviewed the evidence using the GRADE approach and made twenty-four recommendations for VTE prophylaxis, focusing on pharmacological and mechanical methods.
June 11, 2021
A glimpse of what could be a future for surgery..........
November 28, 2020
A relatively recent, open-access, brief viewpoint on the utility of screening for thoracic aortic pathologies.
September 21, 2020
In this article, the authors explored cardiothoracic surgeons' perceptions of health services research and practice guidelines through open-ended, semi-structured phone interviews with cardiothoracic surgeons across the United States, highlighting gaps in the translation of guidelines to clinical practice.
April 14, 2020
Guidance document for the triage of operations for thoracic malignancies produced by the Thoracic Outcomes Research Network. Their recommendations emphasize the importance of shared decision making, transparency and adherence to ethical principals.
August 14, 2019
A comprehensive audio lecture from an academic pathologist on non-malignant pulmonary lesions.
August 7, 2019
Three pioneers of Enhanced Recovery After Surgery discuss why its principles can and should apply to every patient admitted for surgical treatment.
January 10, 2019
Filmed at the 2018 STS Annual Meeting in Fort Lauderdale, Florida, Douglas Wood of the University of Washington in Seattle moderates a debate on the criteria that should be used to select which patients should undergo lung cancer screening.
September 26, 2018
Using the National Cancer Database, the effect of the timing of computed tomography (CT) surveillance after resection of non-small cell lung cancer on survival was investigated. Survival was similar for patients undergoing CTs every three months or every six months compared to those undergoing annual surveillance CTs. More frequent imaging also had